We are live on ! Find out more
DRTS icon

Alpha Tau Medical
DRTS

14 hedge funds and large institutions have $5.92M invested in Alpha Tau Medical in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

17% more funds holding

Funds holding: 12 → 14 (+2)

12% more capital invested

Capital invested by funds: $5.28M → $5.92M (+$639K)

0.67% less ownership

Funds ownership: 1.63% → 0.95% (-0.67%)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
+$795K
2
JP Morgan Chase
JP Morgan Chase
New York
+$693K
3
PF
Phoenix Financial
Israel
+$464K
4
FAM
Fred Alger Management
New York
+$184K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$181K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$553K
2
Capstone Investment Advisors
Capstone Investment Advisors
New York
-$188K
3
Citadel Advisors
Citadel Advisors
Florida
-$185K
4
TRCT
Tower Research Capital (TRC)
New York
-$36K
5
CS
Clear Street
New York
-$30K

DRTS Hedge Fund Activity: Q2 2022 in Review

14 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q2 2022, worth a combined $5.92M — up 12% from $5.28M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DRTS positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was ETF Managers Group, opening a new position worth an estimated $795K. The largest seller was Barclays, cutting an estimated $553K.

  • 14 institutional investors held Alpha Tau Medical (DRTS) as of Q2 2022, up from 12 in Q1 2022.
  • Funds reported $5.92M of Alpha Tau Medical stock for Q2 2022, up 12% quarter-over-quarter.
  • 7 funds opened new Alpha Tau Medical positions in Q2 2022 and 5 closed out, a net change of +2 holders.
  • The largest Alpha Tau Medical buyer in Q2 2022 was ETF Managers Group, an estimated $795K added.
  • The largest Alpha Tau Medical seller in Q2 2022 was Barclays, an estimated $553K sold.

Based on aggregated 13F filings for Q2 2022.